戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  Multifactorial risk factors contributing to neurodevelopmental abnormalities associated with CHD hav
2       Neutralization of TNF-alpha normalized neurodevelopmental abnormalities in infected mice, provi
3 better pathophysiologic understanding of the neurodevelopmental abnormalities observed in neonates ex
4              It will be a matter of time for neurodevelopmental abnormalities, learning disabilities,
5 dystrophy that is frequently associated with neurodevelopmental abnormalities.
6 tion of this process contributes to multiple neurodevelopmental and cognitive disorders.
7 iduals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which th
8 CHD patients and approximately 28% with both neurodevelopmental and extra-cardiac congenital anomalie
9 ctory dysfunction is broadly associated with neurodevelopmental and neurodegenerative diseases and pr
10 ing a translational approach, which combined neurodevelopmental and neurodegenerative mouse models wi
11 Understanding the genetic factors underlying neurodevelopmental and neuropsychiatric disorders is a m
12 res are implicated in the risk for offspring neurodevelopmental and neuropsychiatric disorders, promp
13 hen determining risk factors contributing to neurodevelopmental and neuropsychiatric disorders.
14 of these genes were previously implicated in neurodevelopmental and neuropsychiatric disorders.
15 NA methylation variation in genes related to neurodevelopmental and peroxisomal processes that play a
16 ndritic spines are manifestations of several neurodevelopmental and psychiatric diseases.
17  have revealed their involvement in multiple neurodevelopmental and psychiatric disorders.
18 nsmission, and perturbations are linked with neurodevelopmental and psychiatric disorders.
19         First, we discuss what disorders are neurodevelopmental and why such a grouping is useful.
20 role of BPTF haploinsufficiency in syndromic neurodevelopmental anomalies and extend the clinical spe
21  brain circuitry, and has been implicated in neurodevelopmental as well as neurodegenerative disease
22  1 year, and at age 18 to 24 months' PMA and neurodevelopmental assessments at 18 to 24 months' PMA d
23                                              Neurodevelopmental assessments were completed from 2010
24 mong the most commonly implicated factors in neurodevelopmental autism spectrum disorders (ASD), char
25                  A leading theory holds that neurodevelopmental brain disorders arise from imbalances
26 th [7, 8], suggesting an association between neurodevelopmental changes and cortical organization on
27 r and novel mechanistic link to sex-specific neurodevelopmental changes underlying disease risk.
28 nia (n = 1087) and of carriers of another 41 neurodevelopmental CNVs (n = 484).
29                            Adult carriers of neurodevelopmental CNVs from the general population have
30 associated CNVs and of the group of 41 other neurodevelopmental CNVs had impaired performance on the
31 iffusion imaging as part of the Philadelphia Neurodevelopmental Cohort, we demonstrate that structura
32 ral neuroimaging as part of the Philadelphia Neurodevelopmental Cohort.
33 ectional imaging as part of the Philadelphia Neurodevelopmental Cohort.
34 Intellectual disability (ID) is a prevailing neurodevelopmental condition associated with impaired co
35  be reclassified as an early-childhood-onset neurodevelopmental condition in DSM-5.
36  Autism spectrum disorder (ASD) is a complex neurodevelopmental condition that can be reliably diagno
37 spectrum disorder (ASD) encompasses a set of neurodevelopmental conditions whose striking sex-related
38  spectrum disorders are a group of pervasive neurodevelopmental conditions with heterogeneous etiolog
39 ter organization and 2 commonly co-occurring neurodevelopmental conditions, ASD and ADHD, through bot
40 ne period of life, which may have downstream neurodevelopmental consequences.
41 show that MAE genes are under-represented in neurodevelopmental copy number variants (CNVs) (P<2.2 x
42            We aimed to examine the effect of neurodevelopmental copy number variants (CNVs) on the co
43 nd methyl-DNA binding proteins contribute to neurodevelopmental defects and altered brain plasticity.
44 armacological treatment that may prevent the neurodevelopmental defects caused by prenatal immune act
45 e association between maternal infection and neurodevelopmental defects in progeny is well establishe
46 uscular dystrophy frequently associated with neurodevelopmental defects.
47 ted with variable skeletal abnormalities and neurodevelopmental defects.
48 nd their missense mutations cause a range of neurodevelopmental defects.
49 inant disorder that is best characterized by neurodevelopmental deficits and the presence of benign t
50                The mechanisms underlying the neurodevelopmental deficits associated with CHARGE syndr
51             Mechanisms of disease leading to neurodevelopmental deficits in infected infants remain u
52  is a viable risk factor contributing to the neurodevelopmental deficits observed in ASD.
53  is a viable risk factor contributing to the neurodevelopmental deficits observed in autism spectrum
54           There is also an increased risk of neurodevelopmental delay as we find 20% (11/55) of BHFS
55 al effects and resulted in the prevention of neurodevelopmental delay in the one individual treated b
56                                       Global neurodevelopmental delay is a prominent characteristic o
57 rome in one patient (p.Pro210Leu), to severe neurodevelopmental delay with brain atrophy (p.Ser94Arg)
58  families with HPA who exhibited progressive neurodevelopmental delay, dystonia, and a unique profile
59 sy, acquired hydrocephalus and microcephaly, neurodevelopmental delay, gastrointestinal motility prob
60 se of childhood hearing loss and can lead to neurodevelopmental delay.
61  dose of bevacizumab may reduce the risk for neurodevelopmental disability or detrimental effects on
62 the United States and is the fastest growing neurodevelopmental disability worldwide.
63 ter, in addition to GLUT1, to be involved in neurodevelopmental disability.
64                       Rapid translation from neurodevelopmental discovery to clinical application has
65              Further, modeling human genetic neurodevelopmental disease in the mouse has shown how di
66 ostnatal period by activating a well-defined neurodevelopmental disease pathway and that this phenoty
67 length dependent change in expression in the neurodevelopmental disease Rett syndrome (RTT).
68                                         This neurodevelopmental disease state exhibits neural circuit
69 use autosomal recessive neurodegenerative or neurodevelopmental disease, making yeast Vps13p an impor
70 the microbiome may contribute to symptoms of neurodevelopmental disease.
71 ling progress in understanding the causes of neurodevelopmental diseases such as autism, linking gene
72 ctivity are a transdiagnostic key finding in neurodevelopmental diseases, a characterization of imagi
73 therapy in devastating neurodegenerative and neurodevelopmental diseases.
74 odifier genes are frequently associated with neurodevelopmental diseases.
75 at underlying similarities exist among these neurodevelopmental diseases.
76 re identified among 4,760 trio probands with neurodevelopmental diseases; this is highly unlikely to
77 EMENT Pitt-Hopkins syndrome (PTHS) is a rare neurodevelopmental disorder associated with TCF4 mutatio
78 ICANCE STATEMENT Angelman syndrome (AS) is a neurodevelopmental disorder caused by loss or mutation o
79           Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by mutation or deleti
80 kinase-like 5 (CDKL5) deficiency is a severe neurodevelopmental disorder caused by mutations in the C
81           Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in the g
82        Rett syndrome (RTT) is a debilitating neurodevelopmental disorder caused by mutations in the M
83          Rett syndrome (RTT) is an X-linked, neurodevelopmental disorder caused primarily by mutation
84 endent kinase-like 5 (CDKL5) deficiency is a neurodevelopmental disorder characterized by epileptic s
85 re associated with risk for schizophrenia, a neurodevelopmental disorder characterized by excitatory/
86         Joubert syndrome (JS) is a recessive neurodevelopmental disorder characterized by hypotonia,
87  Fragile X syndrome (FXS) is an undertreated neurodevelopmental disorder characterized by low intelli
88      Here, we describe seven children with a neurodevelopmental disorder characterized by microcephal
89 D) is a childhood-onset neuropsychiatric and neurodevelopmental disorder characterized by the presenc
90  particular; they enable the definition of a neurodevelopmental disorder due to PSMD12 variants, expa
91     Intellectual disability (ID) is a common neurodevelopmental disorder exhibiting extreme genetic h
92           Rett syndrome (RTT) is an X-linked neurodevelopmental disorder in which the MECP2 (methyl C
93 fect of virtual corpus callosotomies and the neurodevelopmental disorder itself.
94  mechanism of LIS1 haploinsufficiency in the neurodevelopmental disorder lissencephaly.
95 tions of microcephalin (MCPH1) can cause the neurodevelopmental disorder primary microcephaly type 1.
96 ied in previously implicated high-confidence neurodevelopmental disorder risk genes, such as CHD2, CT
97 lopment and reveal a potential mechanism for neurodevelopmental disorder risk in pregnancies complica
98                           Schizophrenia is a neurodevelopmental disorder that affects up to 1% of the
99                Fragile X syndrome (FXS) is a neurodevelopmental disorder that is a leading cause of i
100 s system, we find that in Timothy syndrome-a neurodevelopmental disorder that is caused by mutations
101 are the main causes of Kleefstra syndrome, a neurodevelopmental disorder that is characterized by imp
102     Prader-Willi syndrome (PWS) is a genetic neurodevelopmental disorder that presents with hypotonia
103                       Autism is a prevailing neurodevelopmental disorder with a large genetic/genomic
104 f maternal UBE3A causes Angelman syndrome, a neurodevelopmental disorder with some overlapping neurol
105          Autism spectrum disorder (ASD) is a neurodevelopmental disorder with unclear etiology and im
106 ntaining 1 (HUWE1) E3 ubiquitin ligase cause neurodevelopmental disorder X-linked intellectual disabi
107 disorder (ADHD) is the most common childhood neurodevelopmental disorder, and boys are two to three t
108 rotein, disrupt brain function and cause the neurodevelopmental disorder, Glut1 deficiency syndrome (
109          Angelman syndrome (AS) is a genetic neurodevelopmental disorder, most commonly caused by del
110  cynomolgus monkeys serving as a model for a neurodevelopmental disorder, Rett syndrome (RTT), which
111 rt of this gene in association with a severe neurodevelopmental disorder.
112 sights into the nature of schizophrenia as a neurodevelopmental disorder.
113 ene develop Angelman syndrome (AS), a severe neurodevelopmental disorder.
114  variants in 50 genes already established in neurodevelopmental disorders (46 autosomal recessive, 2
115  de novo missense mutations in patients with neurodevelopmental disorders (NDDs) and highlight 35 gen
116 ople with autism spectrum disorder and other neurodevelopmental disorders (NDDs) are behaviorally and
117 d/or sign as potential communicative acts in neurodevelopmental disorders (NDDs), are research questi
118    Altered dendritic morphology is common in neurodevelopmental disorders (NDDs), many of which show
119 cing focused on congenital heart disease and neurodevelopmental disorders (NDDs).
120 -LOF to a set of 1142 de novo vari3ants from neurodevelopmental disorders and find enrichment of path
121 ng evidence that these regions contribute to neurodevelopmental disorders and outline strategies for
122 tions (PMMs) have been implicated in several neurodevelopmental disorders and overgrowth syndromes.
123  the effects of experience in the context of neurodevelopmental disorders and typical neural developm
124             This likely explains why certain neurodevelopmental disorders are characterized by weak g
125                Autosomal recessive inherited neurodevelopmental disorders are highly heterogeneous, a
126                                              Neurodevelopmental disorders are marked by inappropriate
127 ngoing efforts to understand the etiology of neurodevelopmental disorders arising from Ptchd1 deficie
128                            They suggest that neurodevelopmental disorders associated with preterm bir
129 udied interneuron subtype in the etiology of neurodevelopmental disorders characterized by NMDA recep
130                                              Neurodevelopmental disorders have a strong genetic compo
131 to behavioural abnormalities associated with neurodevelopmental disorders in both primate and rodent
132 o induce TH17 cells may increase the risk of neurodevelopmental disorders in the offspring of pregnan
133 sts that common pathways are altered in many neurodevelopmental disorders including autism spectrum d
134 egnancy serves as a risk factor for multiple neurodevelopmental disorders including autism spectrum d
135 evelopment has been implicated in a range of neurodevelopmental disorders including tuberous sclerosi
136 tellectual disability and in the etiology of neurodevelopmental disorders is increasingly recognized.
137 tic approach in consanguineous families with neurodevelopmental disorders is recommended.
138                                              Neurodevelopmental disorders offer a window to addressin
139                               However, human neurodevelopmental disorders related to EBF3 have not be
140 e offspring, resulting in increased risk for neurodevelopmental disorders such as ADHD.
141 l as a key player in conditions ranging from neurodevelopmental disorders such as autism to neurodege
142 at were not previously reported in regard to neurodevelopmental disorders were identified.
143 reatments for FASD and conceivably for other neurodevelopmental disorders with cognitive deficits.
144 utical agents, and can be adapted for use in neurodevelopmental disorders with genetic etiologies.
145 spectrum disorder (ASD) describes a group of neurodevelopmental disorders with high heritability, alt
146 m disorder (ASD) represents a set of complex neurodevelopmental disorders with large degrees of herit
147  this domain and the C-terminal likely cause neurodevelopmental disorders with or without seizures.
148 m disorder (ASD) is a heterogeneous group of neurodevelopmental disorders without any defined uniting
149         After excluding known risk genes for neurodevelopmental disorders, a significant rare variant
150  States, one in six children are affected by neurodevelopmental disorders, and polybrominated dipheny
151 cy is correlated with increased frequency of neurodevelopmental disorders, and this is studied in mic
152 ntial to uncover altered topologies in other neurodevelopmental disorders, as well.
153 er and infections has been linked to various neurodevelopmental disorders, but it is not yet known wh
154 tism and intellectual disability are complex neurodevelopmental disorders, debilitating millions of p
155                                              Neurodevelopmental disorders, including autism spectrum
156 y complications that predispose offspring to neurodevelopmental disorders, including autism, attentio
157 n the impact of a genetic lesion linked with neurodevelopmental disorders, including mechanisms of ma
158 d8(+/del5) mice across pathways disrupted in neurodevelopmental disorders, including neurogenesis, sy
159  lead to epilepsy and are also implicated in neurodevelopmental disorders, neuropathic pain, and schi
160 that is strongly associated with the risk of neurodevelopmental disorders, particularly autism and at
161 ing neural and behavioral dysfunction across neurodevelopmental disorders, particularly autism spectr
162 s associated with the DMSs were enriched for neurodevelopmental disorders, particularly for CpG sites
163 trongly implicated in the pathophysiology of neurodevelopmental disorders, raising the question of wh
164 its in sensory systems are commonly noted in neurodevelopmental disorders, such as the Rett syndrome
165 While altered cIN development contributes to neurodevelopmental disorders, the inaccessibility of hum
166 nderstand the heterogeneity of ASD and other neurodevelopmental disorders, the relationship between q
167 A receptor have already been associated with neurodevelopmental disorders, we suggest that pathogenic
168 onal morphology and synaptic changes seen in neurodevelopmental disorders, while alteration in astroc
169 d an important role for de novo variation in neurodevelopmental disorders.
170 dentified in individuals affected by various neurodevelopmental disorders.
171 ve been tightly associated with the onset of neurodevelopmental disorders.
172 tional domain (TRIO) protein associated with neurodevelopmental disorders.
173 1A2 have recently been found to give rise to neurodevelopmental disorders.
174 ies to neuronal proteins may be one cause of neurodevelopmental disorders.
175 s impacted by genetic risk factors linked to neurodevelopmental disorders.
176  isoform 2 causes phenotypes translatable to neurodevelopmental disorders.
177  possible contribution to pathophysiology in neurodevelopmental disorders.
178 rhaps consistent with their association with neurodevelopmental disorders.
179 ral growth, delayed cerebral maturation, and neurodevelopmental disorders.
180  as a recurring mechanism in the etiology of neurodevelopmental disorders.
181  take into account the strong overlap across neurodevelopmental disorders.
182  (ASD) are common, complex and heterogeneous neurodevelopmental disorders.
183 dentified as the genetic basis of congenital neurodevelopmental disorders.
184  of the molecular mechanisms contributing to neurodevelopmental disorders.
185 werful approach to gene discovery in complex neurodevelopmental disorders.
186 part in the etiology of neuropsychiatric and neurodevelopmental disorders.
187 genes for which mutations are known to cause neurodevelopmental disorders.
188 hose mutation is known to cause ASD or other neurodevelopmental disorders.
189 s concentrated in risk genes associated with neurodevelopmental disorders.
190 c characteristics of individuals affected by neurodevelopmental disorders.
191 ular and molecular defects underlying ID and neurodevelopmental disorders.
192 uide the search for epigenomic mechanisms in neurodevelopmental disorders.
193 ost notable characteristics of this group of neurodevelopmental disorders.
194 are less genetic risk as compared with other neurodevelopmental disorders.
195 associated with a spectrum of epilepsies and neurodevelopmental disorders.
196  behavioural problems and is associated with neurodevelopmental disorders.
197 terodimer) can give rise to severe, sporadic neurodevelopmental disorders.
198 imately 0.1% of individuals with unexplained neurodevelopmental disorders.
199 leads to numerous human neurodegenerative or neurodevelopmental disorders.
200 ) protein may play a key role in HCMV-caused neurodevelopmental disorders.
201 ity of cerebral organoids for modeling human neurodevelopmental disorders.
202  for pathogenic variation related to complex neurodevelopmental disorders.
203 derlying the E/I imbalance hypothesis across neurodevelopmental disorders.
204 s an important underlying molecular cause of neurodevelopmental dysfunction, we developed and charact
205 ted long-term data on potential systemic and neurodevelopmental effects after anti-VEGF use for ROP t
206 erapeutic target to mitigate the deleterious neurodevelopmental effects of prenatal cocaine exposure
207 igenetic programming could explain mercury's neurodevelopmental effects.
208 ults implicate social visual engagement as a neurodevelopmental endophenotype not only for autism, bu
209 PSC models to reveal relevant human-specific neurodevelopmental events.
210 preterm neonates was associated with adverse neurodevelopmental events.
211 impact of early vitamin A supplementation on neurodevelopmental function has not been adequately stud
212 ved CREs are enriched in immune response and neurodevelopmental functions.
213  We applied network analysis to characterize neurodevelopmental gene expression, revealing widespread
214               On chromosome 13, SLITRK6 is a neurodevelopmental gene mostly expressed in the dienceph
215 f mutants, we observed that most but not all neurodevelopmental genes in the Wnt/Frizzled pathway are
216 ting risks of bronchopulmonary dysplasia and neurodevelopmental harm.
217 pwise manner to further our understanding of neurodevelopmental HCMV pathogenesis.IMPORTANCE HCMV bra
218                        Our results support a neurodevelopmental hypothesis of MDD wherein dysfunction
219                        Prior studies suggest neurodevelopmental impacts of polybrominated diphenyl et
220 roup vs 70% in the placebo group), with mild neurodevelopmental impairment (20% in the hydrocortisone
221 e placebo group), or with moderate to severe neurodevelopmental impairment (7% in the hydrocortisone
222         The distribution of patients without neurodevelopmental impairment (73% in the hydrocortisone
223  primary outcome was a composite of death or neurodevelopmental impairment (NDI) at 18 to 24 months c
224 B streptococcal (GBS) disease are at risk of neurodevelopmental impairment (NDI), a burden not previo
225 eptic encephalopathy, of which 13 had severe neurodevelopmental impairment and four died in early chi
226                                  The rate of neurodevelopmental impairment and mortality combined was
227 extremely preterm infants is associated with neurodevelopmental impairment at 2 years of age.
228                  Preterm infants who develop neurodevelopmental impairment do not always have recogni
229 m infants with adverse neonatal outcomes and neurodevelopmental impairment in early childhood, with a
230 xamining the genetic and molecular bases for neurodevelopmental impairment in model mice in vivoSIGNI
231                                              Neurodevelopmental impairment is the most common comorbi
232 respecified exploratory secondary outcome of neurodevelopmental impairment was based on a standardize
233 neurodevelopmental impairment, survival with neurodevelopmental impairment, or death.
234 was a three-level outcome - survival without neurodevelopmental impairment, survival with neurodevelo
235 s: (1) ataxia, (2) spasticity and (3) global neurodevelopmental impairment.
236 ut is often preceded by observable childhood neurodevelopmental impairments.
237 s conclude that early disruptive behavior is neurodevelopmental in nature and should be reclassified
238          Study findings highlight 1 putative neurodevelopmental mechanism by which the association be
239 nd multicellular organisms including various neurodevelopmental model systems.
240 bolite levels in brain homogenates from five neurodevelopmental mouse models of psychiatric disorders
241                          This accords with a neurodevelopmental origin of aberrant brain-wide structu
242 er is a debilitating condition with possible neurodevelopmental origins but unknown neuroanatomical c
243  and environmental factors and correlated to neurodevelopmental outcome at 2 years.
244 ctate lesions to brain development and early neurodevelopmental outcome we used multimodal brain MRI
245 roanatomical abnormalities and adverse early neurodevelopmental outcome.
246 ence a high rate of brain injury and adverse neurodevelopmental outcome; however, the incidence of br
247                     We compared survival and neurodevelopmental outcomes among infants born at 22 to
248 se exposure has been associated with adverse neurodevelopmental outcomes among school-aged children;
249 roid use, respiratory support, survival, and neurodevelopmental outcomes at 18 to 24 months' PMA.
250 hout BPD at 36 weeks' PMA or respiratory and neurodevelopmental outcomes at 18 to 24 months' PMA.
251 changes in NSCs and to link these changes to neurodevelopmental outcomes in children who were exposed
252  prenatal cytokine and chemokine profiles on neurodevelopmental outcomes in humans.
253 l be essential to prevent or improve adverse neurodevelopmental outcomes in individuals surviving CHD
254 dysplasia that best predicts respiratory and neurodevelopmental outcomes in preterm infants.
255 e association between neonatal pain and poor neurodevelopmental outcomes in these high-risk neonates.
256 literature describing risk factor models for neurodevelopmental outcomes in VPT/VLBW children, yet fe
257 and is associated with adverse pulmonary and neurodevelopmental outcomes.
258  additional benefits to long-term growth and neurodevelopmental outcomes.
259 sis, risk of recurrence, and risk of adverse neurodevelopmental outcomes.
260 ation vs medical management and neonatal and neurodevelopmental outcomes.
261 l hotspot associated with an allele-specific neurodevelopmental phenotype in NACC1.
262 aploinsufficiency results in a predominantly neurodevelopmental phenotype with occasional physical an
263                               An overlapping neurodevelopmental phenotype, including severe intellect
264 dividuals who underwent WES for diagnoses of neurodevelopmental phenotypes is extremely small and ach
265 elated disorders comprise a wide spectrum of neurodevelopmental phenotypes ranging from mild to sever
266 patient cohort exhibited a broad spectrum of neurodevelopmental phenotypes, comprising six patients w
267 d13 has been implicated as a major driver of neurodevelopmental phenotypes.
268 mester antidepressant exposure and birth and neurodevelopmental problems.
269  we propose that deprivation accelerates the neurodevelopmental process of synaptic pruning and limit
270 e that maternal immune activation hits a key neurodevelopmental process, the excitatory-to-inhibitory
271 s in the transcription factor THAP1, but the neurodevelopmental processes in which THAP1 participates
272 etween childhood symptoms and the underlying neurodevelopmental processes remains unclear.
273 CMV ie3, interferes pleiotropically with key neurodevelopmental processes, including neural stem cell
274 iver for major mental illness by influencing neurodevelopmental processes.
275 nimal model with translational relevance for neurodevelopmental psychiatric disorders such as schizop
276  cell biology have advanced neurobiology for neurodevelopmental psychiatric disorders.
277  in the etiopathogenesis or manifestation of neurodevelopmental, psychiatric and neurodegenerative di
278 cated in a broad range of diseases including neurodevelopmental, renal, and lung disorders, and cance
279  these de novo variants do not contribute to neurodevelopmental risk.
280 the developing human fetus and can result in neurodevelopmental sequelae.
281                These data link metabolic and neurodevelopmental signaling to social challenge, and id
282 hat underlie this adaptive phenomenon, since neurodevelopmental studies have mainly focused on the ri
283 ationships linking white matter structure to neurodevelopmental symptoms.
284 icate that mutations in EBF3 cause a genetic neurodevelopmental syndrome and suggest that loss of EBF
285 nt dominant mutations in RAB11B leading to a neurodevelopmental syndrome, likely caused by altered GD
286 at de novo mutations in EBF3 cause a complex neurodevelopmental syndrome.
287 ses have been linked to neurodegenerative or neurodevelopmental syndromes.
288 rality, sex, rapid weight gain, and baseline neurodevelopmental test results.
289 mmation demonstrated impaired performance in neurodevelopmental testing in early life assessed via ne
290  differentially expressed energy-related and neurodevelopmental TF genes.
291  for schizophrenia pathogenesis, but also in neurodevelopmental theories, because rodent models indic
292 Bs) and organochlorine pesticides (OCPs) are neurodevelopmental toxicants, but few studies have exami
293 eed acceptable levels defined in relation to neurodevelopmental toxicity in rodents.
294       Taken together, a unified model of the neurodevelopmental toxicity of BMAA in the zebrafish emb
295 a cocktail of BDE congeners with evidence of neurodevelopmental toxicity.
296 ng BDE congener-specific reference doses for neurodevelopmental toxicity.
297 irst years of life, while deviations to this neurodevelopmental trajectory likely result in alteratio
298                           To investigate the neurodevelopmental trajectory of the association between
299 Rosa26 and AAVS1); (2) biallelic knockout of neurodevelopmental transcription factor genes; (3) simpl
300 one resulted in an altered, inflammatory and neurodevelopmental transcriptome profile.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top